• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » 7 medtech stories we missed this week: March 17, 2017

7 medtech stories we missed this week: March 17, 2017

March 17, 2017 By Danielle Kirsh

medtech missed
[Photo from unsplash.com]
The FDA awarded 510(k) clearance to a couple of medtech companies this week while others received tax breaks and incentives, including a local tax break for a $154 million Stryker R&D facility planned in Michigan. Here are 7 medtech stories we missed this week but thought were worth mentioning.

1. FirstRay wins FDA 510(k) clearance for extended Stealth staple line

FirstRay announced that it received FDA clearance for new additions to its Stealth Staple System product line, according to a March 15 news release. The company already had clearance for its standard size implants that were made from titanium alloy. The new clearance covers standard size implants manufactured from PEEK, small implants manufactured from titanium alloy and PEEK and Mini size implants made from titanium alloy.

2. CorVascular inks distribution deal with Novarix for IV-eye

CorVascular Diagnostics, a company that designs and distributes advanced peripheral vascular diagnostic solutions, announced this week that it has reached a distribution deal with Novarix, a company that makes innovative medical devices in Intravenous therapy, according to a March 15 news release. The Novarix-developed IV-eye is a near infrared vein imaging device that helps healthcare professionals find good veins for cannulation and venipuncture. CorVascular will market it IV-eye to national and large regional distributors and will introduce it to resellers in the healthcare segments in the U.S. markets.

3. Stryker wins tax break for $154M Michigan facility

Stryker Instruments announced that it has won a tax break from Portage, Mich., for its research and development facility plans in the city. Construction could begin as early as May, according to a March 15 news release. The facility is estimated to cost $154 million and be 485,000 sq. feet. The Portage City Council unanimously approved the tax break on March 14. The discount on the building will take effect upon completion in 2019.

4. Millar receives FDA 510(k) clearance for pressure catheter

Millar has won FDA 510(k) clearance for its Mikro-Cath pressure catheter, according to a March 14 news release. The 510(k) adds on to previous clearance that the Mikro-Cath received for its use in cardiovascular pressure monitoring and gave greater access to its MEMS pressure sensor for medical providers and researchers. The new clearance allows for it to be used for monitoring intracompartmental and airway pressures. The Mikro-Cath can be used during exercise studies for compartment pressure measurements because it is not affected by patient position or movement.

5. Avita receives Australian grant

Avita Medical announced that it received a Research and Development Tax Incentive cash rebate from the Australian Tax Office, according to a March 15 news release. The cash rebate totaled $974,908 Australian dollars ($751,293.35 in U.S. dollars) for the financial year that ended on June 30, 2016. Research and development tax incentives give tax cash rebates to support Australian companies that are participating in research and development projects.

6. Innovative Cardiovascular Solutions launches embolic protection

Innovative Cardiovascular Solutions announced this week that it had its first successful European clinical case for its Emblok embolic protection systems in patients that are undergoing TAVR procedures, according to a March 15 news release. The procedures were completed at the San Rafaela Hospital in Milan, Italy. TAVR is used in intermediate, high and extreme risk patients who have aortic stenosis and is currently being tested in low-risk patients. These procedures present a risk of neurological events because embolic debris can enter the cerebral, abdominal and distal vasculature during a procedure. The Emblok system is not yet available for sale and is only available for investigational use.

7. Amend Surgical signs license agreement for artificial bone

Amend Surgical signed an exclusive agreement with the University of Florida Research Foundation for the development of the artificial bone substitute, the Biomimetic Bone, according to a March 14 news release. Researchers at the University of Florida developed a process that mineralized collagen substrates with a polymer-induced, liquid-precursor process to create an artificial bone substitute that has the same composition and structure of natural bones. Because of this process, Amend Surgical will be able to create a highly mineralized, load-bearing, bioresorbable, collagen-hydroxyapatite composite that the company claims will be a pioneer in artificial bones.

Here’s what we missed last week.

Filed Under: 510(k), Biotech, Cardiovascular, Clinical Trials, Food & Drug Administration (FDA), Legal News, Regulatory/Compliance, Research & Development Tagged With: Amend Surgical, avitamedical, CorVascular, FirstRay, Innovative Cardiovascular Solutions, MedTech, Millar, Novarix, Stryker, University of Florida

In case you missed it

  • 3M Health Care Business president is leaving this year
  • Device developer SeaStar Medical hires chief medical officer
  • AccuPulse raises $10M Series A
  • Exactech announces first U.S. surgeries with its nex-gen laser cage glenoid
  • Baxter expects sales growth momentum through 2025
  • Vivera picks up new patent for electronic dose-controlled drug delivery devices
  • Stryker launches dynamic compression system for foot, ankle applications
  • Entegris opens Life Sciences Technology Center in Massachusetts
  • Glucose monitor maker Know Labs expands leadership team
  • inHeart wins FDA clearance for 3D cardiac modeling software
  • How Glytec is advancing insulin management in the hospital
  • Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension
  • FDA clears RapidAI’s pulmonary embolism triage platform
  • Report: Dexcom in talks to acquire Insulet
  • Henry Schein investors push back on executive pay
  • Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
  • Creo Medical inks collaboration agreement with Intuitive

RSS From Medical Design & Outsourcing

  • 3M Health Care Business president is leaving this year
    3M Health Care Business Group President Mojdeh Poul will retire from the company on July 1, 2022. Poul joined Maple Grove, Minnesota-based 3M (NYSE:MMM) in 2011 as the global business VP of critical and chronic care solutions. She later became VP and general manager of the company’s food safety business and president of numerous 3M… […]
  • Iterative Scopes announces positive data in Skout AI colonoscopy algorithm clinical trial
    Iterative Scopes this week announced positive trial data in a study of its colorectal cancer screening algorithm, Skout. Cambridge, Massachusetts-based Iterative Scopes designed Skout as a computer-aided device (CADe) that uses artificial intelligence and computer vision technology to detect suspicious tissue and provide real-time feedback for gastroenterologists performing the procedure. Get the full story on… […]
  • Device developer SeaStar Medical hires chief medical officer
    SeaStar Medical has hired Dr. Kevin Chung as chief medical officer of the medtech developer starting July 1. Denver-based SeaStar is developing a platform therapy focused on hyperinflammation of vital organs. The company’s Selective Cytopheretic Device was designated as a breakthrough device by the FDA earlier this year. SeaStar is set to go public in… […]
  • Varta presents microbattery product portfolio at Computex 2022
    Varta will present its broad product portfolio of microbatteries, which make a wide range of future-proof applications possible, at Computex in Taipei starting today. Varta’s microbattery product portfolio ranges from rechargeable lithium-ion button cells to nickel metal hydride button cells, primary silver oxide cells, primary lithium button cells and cylindrical lithium batteries to hydrogen gas… […]
  • Entegris opens Life Sciences Technology Center in Massachusetts
    Entegris (Nasdaq:ENTG) announced today that it opened a new Life Sciences Technology Center in Billerica, Massachusetts. The new Life Sciences Technology Center was built to offer life sciences customers the opportunity to leverage Entegris’ cold-chain supply expertise to optimize processes, reduce costs and increase speed to market. Get the full story at our sister site,… […]
  • MedAcuity hires SVP of business development
    Medtech software development firm MedAcuity today said it has hired Simon Johnson as SVP of business development. Westford, Massachusetts-based MedAcuity said Johnson previously built the client partner team and managed strategic clients at digital consultancy Mobiquity. He also served as SVP of client services at GreenPages Technologies, responsible for driving services revenue growth leading to… […]
  • Henry Schein investors push back on executive pay
    Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May… […]
  • Creo Medical inks collaboration agreement with Intuitive
    Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday… […]
  • MedTrace Pharma moves forward on 15 O-water imaging tech
    MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate… […]
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS